Estabrook Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$44
-99.9%
140.0%0.00%
Q3 2022$69,000
+19.0%
140.0%0.00%
Q2 2022$58,000
-28.4%
140.0%0.00%
Q1 2022$81,000
-22.9%
140.0%0.00%
Q4 2021$105,000
-16.7%
140.0%0.00%
Q3 2021$126,000
-25.0%
140.0%0.00%
Q2 2021$168,000
-4.0%
140.0%0.00%
Q1 2021$175,000
-19.7%
140.0%0.00%
Q4 2020$218,000
+65.2%
140.0%0.00%
Q3 2020$132,000
+5.6%
140.0%0.00%
Q2 2020$125,000
+40.4%
140.0%0.00%
Q1 2020$89,000
-23.9%
140.0%0.00%
Q4 2019$117,000140.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders